Global Blood Glucose Monitoring Market Size, Status and Forecast 2021-2027

One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. The key is balancing your food with your activity, lifestyle and diabetes medicines. Blood glucose monitoring can help you understand the link between blood glucose, food, exercise and insulin.

Market Analysis and Insights: Global Blood Glucose Monitoring Market
The global Blood Glucose Monitoring market size is projected to reach US$ 10610 million by 2027, from US$ 7877 million in 2020, at a CAGR of 3.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Glucose Monitoring market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Glucose Monitoring market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Glucose Monitoring market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Glucose Monitoring market.

Global Blood Glucose Monitoring Scope and Market Size
Blood Glucose Monitoring market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Glucose Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems

Segment by Application
Hospitals Diagnostic Centers
Home Settings
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation